Depression associated with medical illness - Treatment considerations

被引:36
作者
Fava, GA [1 ]
Sonino, N [1 ]
机构
[1] UNIV PADUA,IST SEMEIOT MED,I-35100 PADUA,ITALY
关键词
D O I
10.2165/00023210-199605030-00004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Depressive symptoms are highly prevalent in the medically ill, and may affect quality of life, social functioning, and compliance and the outcome of treatments for medical illness. There is evidence that depression in medical patients is frequently unrecognised and untreated. Its evaluation requires both the assessment of severity (whether it reaches the clinical threshold of a major depressive disorder) and determination of aetiology (symptomatic or organic mood disorders). Treatment of symptomatic depression follows the treatment, whenever it is feasible, of the underlying medical condition. Antidepressant drugs are the treatment of choice for major depressive disorders in the medically ill, and are well tolerated in patients with a number of medical conditions, provided that specific precautions are heeded. In the medically ill, tricyclic antidepressants appear to still present considerable advantages over second generation antidepressants, such as selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors. Psychotherapeutic interventions have considerable potential, currently largely unexplored in controlled studies, for the treatment of depression in the medically ill. Electroconvulsive therapy (ECT) remains an effective modality for refractory depression and can be used safely in a number of medical conditions.
引用
收藏
页码:175 / 189
页数:15
相关论文
共 127 条
[1]   PHEOCHROMOCYTOMA UNMASKED BY DESIPRAMINE THERAPY [J].
ACHONG, MR ;
KEANE, PM .
ANNALS OF INTERNAL MEDICINE, 1981, 94 (03) :358-359
[2]   MULTIDISCIPLINE TREATMENT OF CHRONIC PULMONARY INSUFFICIENCY .1. PSYCHOLOGIC ASPECTS OF REHABILITATION [J].
AGLE, DP ;
BAUM, GL ;
CHESTER, EH ;
WENDT, M .
PSYCHOSOMATIC MEDICINE, 1973, 35 (01) :41-49
[3]   USE OF LITHIUM IN THE MEDICALLY ILL [J].
AMDISEN, A ;
HILDEBRANDT, J .
PSYCHOTHERAPY AND PSYCHOSOMATICS, 1988, 49 (02) :103-119
[4]   HEPATIC-DISEASE AND PSYCHIATRIC-ILLNESS - RELATIONSHIPS AND TREATMENT [J].
ANANTH, J ;
SWARTZ, R ;
BURGOYNE, K ;
GADASALLY, R .
PSYCHOTHERAPY AND PSYCHOSOMATICS, 1994, 62 (3-4) :146-159
[5]   PSYCHOTROPIC AND MEDICAL DRUG-INTERACTIONS [J].
ANANTH, J ;
JOHNSON, K .
PSYCHOTHERAPY AND PSYCHOSOMATICS, 1992, 58 (3-4) :178-196
[6]   PSYCHOPHARMACOLOGICAL AGENTS IN PHYSICAL DISORDERS [J].
ANANTH, J .
PSYCHOTHERAPY AND PSYCHOSOMATICS, 1992, 58 (01) :13-31
[7]  
ANDERSEN J, 1980, ACTA NEUROL SCAND, V62, P210
[8]  
[Anonymous], 1992, The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines
[9]  
AVERY D, 1976, ARCH GEN PSYCHIAT, V33, P1029
[10]  
BECH P, 1993, J CLIN PSYCHIAT, V54, P18